Your prediction
Novozymes A/S B Stock
The Novozymes A/S B stock is trending slightly upwards today, with an increase of €0.37 (0.800%) compared to yesterday's price.
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | 0.800% | -3.063% | -10.725% | -16.011% | -15.029% | 1.196% | -12.307% |
| Solvay S.A. A | -1.690% | -5.743% | -9.485% | -27.567% | -9.883% | -74.949% | -76.839% |
| Covestro AG | -0.700% | -0.600% | -1.779% | 2.370% | -0.931% | 60.355% | 7.038% |
| FMC Corp. | -5.360% | -7.633% | -8.340% | -70.803% | -2.736% | -89.739% | -87.680% |
